- Home
- CRIS vs GLXG Comparison
CRIS vs GLXG Comparison
Compare CRIS & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- GLXG
- Stock Information
- Founded
- CRIS 2000
- GLXG 2013
- Country
- CRIS United States
- GLXG Hong Kong
- Employees
- CRIS 33
- GLXG N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- GLXG
- Sector
- CRIS Health Care
- GLXG
- Exchange
- CRIS Nasdaq
- GLXG NYSE
- Market Cap
- CRIS 13.5M
- GLXG 16.0M
- IPO Year
- CRIS 2000
- GLXG 2024
- Fundamental
- Price
- CRIS $1.50
- GLXG $0.58
- Analyst Decision
- CRIS Strong Buy
- GLXG
- Analyst Count
- CRIS 3
- GLXG 0
- Target Price
- CRIS $21.00
- GLXG N/A
- AVG Volume (30 Days)
- CRIS 102.7K
- GLXG 4.3M
- Earning Date
- CRIS 05-06-2025
- GLXG 05-16-2025
- Dividend Yield
- CRIS N/A
- GLXG N/A
- EPS Growth
- CRIS N/A
- GLXG N/A
- EPS
- CRIS N/A
- GLXG 0.04
- Revenue
- CRIS $10,908,000.00
- GLXG $3,858,088.00
- Revenue This Year
- CRIS $2.33
- GLXG N/A
- Revenue Next Year
- CRIS $9.78
- GLXG N/A
- P/E Ratio
- CRIS N/A
- GLXG $12.93
- Revenue Growth
- CRIS 8.83
- GLXG N/A
- 52 Week Low
- CRIS $1.02
- GLXG $0.55
- 52 Week High
- CRIS $16.99
- GLXG $16.93
- Technical
- Relative Strength Index (RSI)
- CRIS 37.70
- GLXG N/A
- Support Level
- CRIS $1.06
- GLXG N/A
- Resistance Level
- CRIS $1.30
- GLXG N/A
- Average True Range (ATR)
- CRIS 0.15
- GLXG 0.00
- MACD
- CRIS 0.07
- GLXG 0.00
- Stochastic Oscillator
- CRIS 70.59
- GLXG 0.00
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.